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In this review we discuss how the competition for cytokines between different cells of the
immune system can shape the system wide immune response. We focus on interleukin-2
(IL-2) secretion by activated effector T cells (Teff) and on the competition for IL-2 consump-
tion betweenTeff and regulatoryT cells (Treg). We discuss the evidence for the mechanism
in which the depletion of IL-2 by Treg cells would be sufficient to suppress an autoimmune
response, yet not strong enough to prevent an immune response. We present quantitative
estimations and summarize our modeling effort to show that the tug-of-war between Treg
and Teff cells for IL-2 molecules can be won by Treg cells in the case of weak activation
of Teff leading to the suppression of the immune response. Or, for strongly activated Teff
cells, it can be won byTeff cells bringing about the activation of the whole adaptive immune
system. Finally, we discuss some recent applications attempting to achieve clinical effects
through the modulation of IL-2 consumption by Treg compartment.
Keywords: computational modeling, cytokine competition, IL-2, regulatoryT cells, systems immunology
INTRODUCTION
Recent studies, specifically on the role of IL-2 in the regulation
of immune responses, have highlighted how cytokine compe-
tition may be a critical determinant to arbitrate the balance
between tolerance and response, and/or to channel the activation
of lymphocytes toward specific differentiation paths.
Cytokines are ubiquitous in immunology as mediators of cell–
cell communications. Most knock-out mouse models of cytokines
(with the notable exception of IFNγ) display critical and often
deadly pathologies. For example, IL-2 knock-out mice are rid-
dled with systemic autoimmune disorders (Horak et al., 1995),
explained by the abrogated development and maintenance of
regulatory T cells in peripheral lymphoid organs. On the other
hand, there exist few clinical protocols whereby perturbations of
cytokine pathways lead to clinical therapies. This review aims
at presenting the need of quantitatively understanding cytokine
function as a basis for more targeted therapeutic manipulation.
We will discuss how the balance between cytokine secretion
and consumption by multiple cell types fine-tunes the immune
response.
This review is organized in four parts. First, we review recent
experimental work addressing the role of cytokine consumption.
Second, we present basic quantitative facts that highlight the explo-
siveness of cytokine secretion as well as the importance of cytokine
consumption for lymphocyte–lymphocyte communication. We
focus on IL-2 secretion and uptake as the best modeled case of
cytokine competition, and also because it is a “self-contained” reg-
ulatory system (secreted by T cells, consumed by T cells). Third
we summarize recent theoretical studies that addressed the role of
IL-2 competition as a mechanism of suppression by regulatory T
cells. Finally, we discuss the biological relevance of these theoretical
efforts toward better understanding immunological regulations.
THREE EXPERIMENTAL EVIDENCES AGAINST A ROLE FOR
IL-2 DEPLETION AS A MECHANISM FOR Treg SUPPRESSION
CAN BE MITIGATED
The original identification of the CD4+CD25+ compartment as
a key population to enforce peripheral tolerance (Sakaguchi et al.,
1995) led to the conjecture that IL-2Rα played a critical role in
Treg function. Given the critical role of IL-2 for T cell survival
and proliferation in vitro, many researchers originally conjectured
that IL-2 depletion by Treg cells would be a critical mechanism to
enforce their suppressive capabilities. However, the autoimmunity
observed in IL-2 knock-out mice drew into question an activating
function for IL-2 for T cell immune responses in vivo (Kundig et al.,
1993). A partial resolution of this perceived conundrum came
from the observation that the development and maintenance of
Treg cells depends on IL-2, so that IL-2 was attributed an immuno-
suppressive – rather than an activating – function in vivo. However,
careful studies that went beyond the constitutive IL-2 knock-out
model have since demonstrated that the action of IL-2 on both
CD4+CD25− and CD8+ T cells supports immune response in
multiple ways (e.g., by sustaining different modes of proliferation
of CD8+ T cells; Kundig et al., 1993; Williams et al., 2006; Cho
et al., 2007), furthering the survival of CD4+T cells (Dooms et al.,
2004), and driving CD4 effector and memory cell differentiation
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(Yamane et al., 2005; Chen et al., 2011; Pandiyan et al., 2011).
Thus IL-2 serves dichotomous functions in the suppression and
enhancement of adaptive immunity.
While these studies open the possibility of an immunosup-
pressive role for IL-2 consumption by Treg cells, experiments
at the turn of the millenium have further challenged this idea.
For example, experiments with a knock-out genetic model for
the IL-2Rβ chain (CD122) delivered negative results regarding
the role of IL-2 depletion by Tregs as a mechanism of suppres-
sion of autoimmune response. Specifically, Malek et al. (2002)
relied on a thymic-transgenic expression of wild-type IL-2Rβ to
drive the development of CD4+CD25+ T cells in the thymus
then abrogate expression of IL-2Rβ in the periphery. These mice,
whose peripheral lymphoid tissues contained CD4+IL-2Rα+IL-
2Rβ− Treg cells, were devoid of autoimmune disorders, while
mice from straight IL-2Rβ−/−models lacked CD4+CD25+ cells
and suffered systematic autoimmune attacks, analogously with
IL-2Rα−/− models. This experimental observation was further
analyzed and interpreted in terms of functional suppressive capa-
bilities among IL-2Rβ-deficient Treg cells, challenging the role of
IL-2 signaling for Treg suppression. However, more recent work
mitigated this conclusion with the observation that peripheral Treg
cells from these IL-2Rβ thymic-transgenic knock-out mice retain
their capabilities, albeit diminished, to respond to IL-2 (Bayer et al.,
2007). These experimental inconsistencies may be explained by the
recycling and long-term stability of the IL-2Rβ receptor, even after
abrogation of its expression in the periphery. Hence, the accurate
peripheral tolerance and lack of autoimmune disorders in IL-2Rβ
thymic-transgenic knock-out mice can no longer be interpreted as
a complete rejection of IL-2 depletion as a necessary mechanism
for Treg suppression.
The discovery of FoxP3 as the transcription factor that identifies
unequivocally the Treg lineage clarified the field, by offering a pro-
prietary marker for Treg that distinguishes them from transiently
expressing CD4+CD25+ effector T cells. Work by the Rudensky
lab (Fontenot et al., 2005) clearly established the critical role of IL-
2 signaling for Treg development and maintenance. On the other
hand, this study showed that FoxP3+CD4+ cells from Il2ra−/−
mice were as suppressive as Treg from Il2ra-sufficient mice, at
least in the classical in vitro proliferation assay: this observation
(among others) again led to the conclusion that IL-2 signaling is
dispensable for suppression. On the other hand, IL-2 signaling for
Il2ra−/− FoxP3+ cells was not quantified and it is possible that
compensatory mechanisms – e.g.,upregulation of beta and gamma
chains of the IL-2R receptors (Li et al., 2001) – would enable these
IL-2Rα deficient cells to maintain their ability to respond and
deplete IL-2. In particular, IL-2Rα−/− T cells have been shown
to respond to IL-2, albeit at higher concentrations (1 nM instead
of the characteristics 10 pM): this could explain why IL-2Rα−/−
mice (that have FoxP3+ peripheral cells but at lower frequency
than IL-2Rα sufficient mice) still suffer from systemic autoim-
mune disorders (a hallmark of defective suppression by Treg) but
with less intensity than IL-2−/−mice (these mice are completely
devoid of FoxP3+ cells).
A third line of experiments has previously been used to reject
cytokine depletion as a mechanism for Treg suppression and have
led to the dogma that cell–cell contact between Treg cells and
Teff cells is absolutely required for suppression. In the past, many
groups (Shevach et al., 1998; Takahashi et al., 1998; Nakamura
et al., 2001; Dieckmann et al., 2002; Xu et al., 2003) have used the
classical transwell assay whereby Treg-Teff contacts are forbidden
by a membrane separation and found that this abolishes suppres-
sion of Teff proliferation by Treg cells. Unfortunately, this setup
can potentially generate false-negative results – as originally sug-
gested in Scheffold et al. (2005), Pandiyan et al. (2007). Indeed,
as pointed out by Shevach (2009) in a recent review, “It should be
emphasized that the failure to observe suppression when Treg cells
are separated from the responder cells by a membrane does not rule
out the possibility that Treg cells secrete an as yet uncharacterized
cytokine that functions in a gradient fashion and requires proximity
between suppressor and responder.” In this regard, it is noteworthy
that the transwell geometry typically separate Treg and Teff cells by
4 mm when one uses the same Corning Costar transwell within
a 24-well plate as described in Thornton and Shevach (1998).
This is a very large distance to be bridged by diffusion. For IL-
2 (a globular protein of 17 kDa), the coefficient of diffusion D
in solution is of the order of 1× 10−6 cm2/s (Weidemann et al.,
2011). Thus the characteristic diffusion time τD across d = 4 mm
is: τD= d2/(2D)= 40000 s= 11 h. Hence, the physical separation
imposed by the transwell geometry implies a large time-delay
between the secretion of soluble molecules by Teff cells and their
potential sensing (and scavenging) by Treg cells (this time-delay
might in fact be even larger, τmixing > 20 h, due to the low porosity
of the transwell membrane). Under these conditions, paracrine
and autocrine consumption of IL-2 by the Teff population, rather
than competitive take-up by the very distant Treg cells will dom-
inate (Scheffold et al., 2007; Busse et al., 2010; Feinerman et al.,
2010). Thus abrogation of suppression in a Teff-Treg transwell
setup (Takahashi et al., 1998; Thornton and Shevach, 1998) does
not rule out cytokine competition as one of the mechanisms of
Treg action (Scheffold et al., 2007). All in all, there is consensus in
the field of regulatory T cells, regarding IL-2, that this cytokine is
critical for the development and maintenance of this subpopula-
tion. On the other hand, the three main lines of evidence dismiss
the functional significance of IL-2 signaling in terms of the Treg
cells’ suppressive capacities may not be definitive.
FUNCTIONAL EVIDENCE FOR IL-2 COMPETITION AS ONE
MECHANISM FOR Treg SUPPRESSION
The renaissance for IL-2 depletion as a mechanism for Treg sup-
pression came with studies from the Scheffold and Stockinger
groups (de la Rosa et al., 2004; Barthlott et al., 2005; Branden-
burg et al., 2008). Both groups documented how IL-2 depletion or
blockage phenocopied the effect of Treg cells on antigen-activated
T cells. Conversely, either the exogenous addition of IL-2 or the
blocking IL-2 uptake by Treg cells only – and not by Teff cells – was
sufficient to abrogate suppression in vitro. Hence, IL-2 was conjec-
tured to be a limiting factor for Teff cell expansion in vitro. These
groups then demonstrated that Teff cells do produce IL-2 (despite
reduced transcription of the IL-2 gene). An early predictor of sup-
pressed Teff cell expansion in these experiments was the lack of
strong IL-2Rα expression on Teff cells, accompanied in a recipro-
cal manner by further upregulation of IL-2Rα on Treg cells. This
behavior is readily explained by competitive IL-2 consumption
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through Treg cells, as pSTAT5 drives IL-2Rα upregulation in both
cell types. This reciprocal regulation of IL-2Rα in Teff and Treg
cells has also been observed in vivo (Klein et al., 2003; Barthlott
et al., 2005). Of note, IL-2 has been shown to prime Treg cells for
later expression of the immunosuppressive cytokine IL-10 in vitro
and in vivo (Barthlott et al., 2005; Brandenburg et al., 2008).
These papers were followed by the comprehensive study by
the Lenardo group (Pandiyan et al., 2007) that focused on
the enhanced apoptosis among activated effector cells, when
common-gamma chain (γc) cytokines are missing because of their
depletion by Treg cells. All the hallmarks of cytokine deprivation-
induced apoptosis (loss of phosphorylation of AKT, phosphoryla-
tion of BAD, membrane blebbing, resistance to death in Bim−/−
mutants) were observed in the suppression assay in vitro. More-
over, Pandiyan et al. (2007) reported the measurements of reduced
IL-2 concentration in supernatants of Teff-Treg cocultures com-
pared to Teff-only cultures: this was assigned to IL-2 consumption
by Treg cells rather than to reduced IL-2 production by Teff cells.
The measured IL-2 concentrations (around 1 unit/ml, i.e., 10 pM)
were exactly in the range where maximal functional impact would
be expected (see following section for details). Finally, a model of
inflammatory bowel disease (IBD) was used as an in vivo assay of
Treg function: upon adoptive co-transfer of CD4+CD25+ T cells
in SCID mouse, the onset of IBD was abrogated and colitogenic
Teff cells were shown to undergo apoptosis. Vice versa, when mice
were not injected with CD4+CD25+ T cells, adoptively trans-
ferred CD45 T cells would proliferate and trigger IBD. Hence,
Pandiyan et al. (2007) made a convincing case that depletion of
IL-2 by Treg cells constitute a critical mechanism to account for
Treg suppression.
QUANTITATIVE ASPECTS OF CYTOKINE ACCUMULATION
AND CONSUMPTION
Addressing the role of cytokine depletion in enforcing suppres-
sion by Treg cells depends on the quantitative understanding of
the dynamics of cytokine accumulation and consumption in the
extracellular medium of lymphoid organs. Of note, most cytokines
are functional in concentration ranges (below 100 pM) that are
unusual for most biological systems. Indeed, most ligand-receptor
interactions, most hormones and growth factors operate in 10 nM
to 10µM range. Hence, there are specific challenges of the bio-
physics of cell–cell communication in the pM range that we need
to address. In this section, we summarize the numbers related
to IL-2 secretion and uptake, and estimate the kinetics of IL-2
accumulation in a lymph node. We note that the experimental
uncertainties for kinetic rates and receptor numbers are rather
large, so the correct parameter values might be within a factor
of 2–3 from the stated value. In addition the receptor numbers
and secretion rates are broadly distributed within the popula-
tion and depend on the experimental protocols of measurement.
Accordingly, we will keep our estimations simple, favoring clarity
while aiming to stay within an order of magnitude of the actual
parameter values.
First, we will briefly describe the kinetic steps involved in IL-2
signaling and consumption by T cells following the model pre-
sented in Feinerman et al. (2010). In general, IL-2 consumption
by T cells proceeds in three steps (Feinerman et al., 2010):
1) Free IL-2 molecules reversibly bind α chains (IL-2Rα)
of IL-2 receptors with characteristic on- and off-rates of
kweak(+)= 1.4 107/(M∗s), kweak(−)= 0.4/s.
IL-2+ IL-2Rα↔ IL-2∗IL-2Rα
2) IL-2∗IL-2Rα locks into a tight complex with available IL-
2Rβ and γc chains of the IL-2 receptor with characteristic
on- and off-rates of k2(+)= 3× 10−4/s, k2(−)= 2.3× 10−4/s,
forming a complete IL-2∗IL-2R receptor.
IL-2∗IL-2Rα+ IL-2Rβ∗γc ↔ IL-2∗IL-R
The assembly of the tetrameric cytokine/receptor complex trig-
gers the phosphorylation of the transcription factor STAT5 into
pSTAT5. pSTAT5 molecules dimerize and enter the cell nucleus
where they regulate a variety of genes, among them many genes
associated with cell survival and proliferation. Importantly
within the context of IL-2 communication, pSTAT5 upregu-
lates the expression of IL-2Rα and downregulates the secretion
of IL-2.
3) IL-2∗IL-R complex is internalized by the cells with the rate of
kendocytosis= 1.1× 10−3/s= (15 min)−1 (Duprez and Dautry-
Varsat, 1986; Duprez et al., 1988, 1991; Hemar et al., 1995). We
assume further that upon internalization the IL-2R receptor
chains return to the cell membrane. This constitutes a simple
way to model the conditions at the cell membrane as quasi-
stationary. In experiments, the quasi-stationary conditions are
supported by the fact that cytokine consumption dynamics
happens at the time scales of several minutes, while the num-
bers of receptor chains remain stable over the course of several
hours.
For the kinetic rates and numbers of receptors chains typical for
T cells, the two-step model for IL-2 binding and uptake gives the
number N R of assembled IL-2∗IL-R complexes per cells as:
NR ≈ Nβγ
1+ KNα[IL−2]
(1)
and the IL-2 consumption rate by the cell of
Jcons = kendocytosisNR ≈
kendocytosisNβγ
1+ KNα[IL−2]
(2)
where K =
(
k2(−)+kendocytosis
)
kweak(−)
kweak(+)k2(+) and N α, N βγ are the numbers
of IL-2Rα and of IL-2Rβ∗γc complexes per cell respectively.
The first main consequence of this model is that the EC50 for
IL-2 signaling (defined as the concentration of IL-2 that yields 50%
of the pSTAT5 response) is inversely proportional to the number
of IL-2Rα chains per cell. In particular, for a moderately activated
T cell with N α≈ 104, EC50∼10 pM, while for a strongly activated
T cell with N α≈ 105, EC50 ∼1 pM. The second consequence of
the model is that at high IL-2 concentrations ([IL-2] EC50),
IL-2 signaling and consumption reach saturation and are limited
by the number of IL-2Rβ∗γc complexes that has been estimated
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to be ∼300 in the naïve T cell and rises to ∼1000 upon activa-
tion (Feinerman et al., 2010). In general, this number appears to
be limited by the number of available γc chains: although there
typically ∼5000–8000 of them per cell, they are shared between
many types of different cytokine receptors: the best estimates for
the number of available γc came from fitting IL-2 consumption
by Treg cells (Feinerman et al., 2010). Notice that the consumption
rate being rather low kendocytosis= 1.1× 10−3/s, a strongly acti-
vated cell exposed to saturating concentrations of IL-2 would be
able to consume at most one molecule of IL-2/s.
IL-2 secretion starts only upon activation of naïve T cells with
foreign antigens. Within hours of activation through their TCR
signaling pathways, effector T cells start secreting IL-2 at an aver-
age rate of ∼10 molecules/s (our unpublished data). As IL-2 is
secreted in the extracellular medium, it diffuses away from the
secreting cell and the IL-2 field around the cell is established with
the maximal concentration near the cell with a characteristic decay
length of about cell radius R. The IL-2 concentration near the cell
c0 is set by the balance between IL-2 secretion and its diffusion:
Jsec = 4piR2D∇c ≈ 4piR2D c0
R
c0 ≈ Jsec
4piRD
(3)
where D is the diffusion coefficient for IL-2. Its value in an aqueous
buffer is∼100µm2/s, but the diffusion coefficient within a lymph
node is not known. Assuming that the viscosity of the extracellu-
lar matrix is similar to that of the cell cytoplasm (∼6 times higher
than that of aqueous solution), we could estimate D∼ 16µm2/s.
Then using R≈ 5µm, we arrive at c0≈ 20 pM, which is larger
than EC50 of even moderately activated T cells. Thus an acti-
vated secreting cell should be able to sense IL-2 it produces in
an autocrine manner. However, at the onset of activation T cells
lack IL-2Rα chain and would need concentrations of IL-2 larger
than 1 nM to respond to it. The expression of IL-2Rα is initiated
upon cell activation, and within 24–48 h the number of IL-2Rα
reaches ∼104–105 per cell lowering EC50 to ∼1–10 pM of IL-2
and allowing for cell sensing its own field of IL-2.
However, even a strongly activated cell would consume only a
small fraction of secreted IL-2 in an autocrine matter. Indeed, as
discussed above a strongly activated T cell can consume at most
∼1 IL-2 molecule/s while producing 10 molecules/s on average.
The rest of the molecules would in principle accumulate within
the lymph node and contribute to communication between dif-
ferent T cells and to coordination and strengthening of the system
immune response. Assuming there are ∼200 activated T cells
in a draining lymph node ∼48 h after immunization (there are
typically few hundreds T cells in a body tuned to activate to a par-
ticular peptide, not all of them will reach the lymph node and
those activated in the node will experience 1–2 divisions dur-
ing that time) and taking the volume of a lymph node to be
1µl, we estimate that the IL-2 concentration in the node would
reach 48 h× (3600 s/h)× (10 molecules/s/cell)× (200 cells)/1µl/
N Avogadro∼ 600 pM within 48 h of secretion. Such IL-2 con-
centration should indeed allow for strong signaling and cross
communication between activated T cells. Specifically, even weakly
activated cells (i.e., cells with lower levels of IL-2Rα would be
able to phosphorylate STAT5: cell–cell communication through
IL-2 would be rather unspecific and universal for all T cells in a
lymphoid organ.
However, such accumulation of IL-2 is prevented by regulatory
T cells. Unlike naïve T cells, Treg cells express constitutively all
of the chains of IL-2R even in homeostasis (∼104 of IL-2Rα and
∼300 of IL-2Rβ∗γc) and can consume IL-2 from the onset of an
immune response. Thus concentration of IL-2 will be established
by the balance of overall secretion rate by Teff cells and the con-
sumption rate by Treg cells. There are ∼5 106 T cells in a lymph
node and ∼5% among them are Treg cells, i.e., ∼2.5 105 cells.
Comparing their consumption rate from Eq. 2 to the secretion
rate of 200 activated T cells (i.e., 2000 molecules/s), we estimate
that in first 24–48 h, IL-2 concentration does not exceed 0.15 pM.
This level is too low for signaling to occur, so there will be almost
no cross talk between different Teff cells. Similarly, with the excep-
tion of cells in the immediate vicinity of a secreting Teff cell, the
majority of Treg cells do not activate their pSTAT5 and downstream
genes.
For an efficient cross talk to occur, the IL-2 concentration has to
rise about tenfold to∼1 pM,which is achieved when the number of
activated T cells reaches∼2000, which could take another 24–48 h.
Well activated Teff cells (with EC50 ∼1 pM) signal much more
efficiently than the majority of Tregs (EC50∼10 pM) at these IL-2
concentrations. As described above, IL-2 signaling leads to upregu-
lation of IL-2Rα expression and therefore to yet stronger signaling
by Teff cells allowing them from that stage onward to win over Tregs
in the competition for IL-2. Only a minority of Treg cells, those in
the immediate vicinity of a secreting cell, have chances to keep up
with Teff cells. The number of such Treg cells can be estimated from
the probabilistic argument: since in a close packed situation each
cell has ∼12 neighbors and 5% of those are Tregs, the number of
strongly signaling Treg cells should be∼60% of activated T helper
cells. However, as Teff further proliferate the importance of IL-2
consumption by Tregs becomes negligible (Sojka et al., 2005, 2008).
IL-2 secreted by the weakly activated (e.g., autoimmune) Teff cells
would be consumed mostly by Treg cells; the Teff cells would not
be able to cross-communicate and their response would be sup-
pressed. Yet Teff cells strongly activated by the foreign proteins will
be able to eventually overcome the suppression, and to exchange
IL-2 cytokines and coordinate their response.
In addition to the competition between Teff and Treg cells,
there exists competition for IL-2 within the Teff system. As noted
above, IL-2 signaling pathway leads to both upregulation of the
expression of IL-2Rα and downregulation of IL-2 secretion. This
means that Teff cells that got more IL-2Rα signal stronger than
others, which leads them to express more IL-2Rα and achieve yet
stronger signaling capabilities. At the same time, they produce less
and less of IL-2. Thus these two feedbacks are two mechanisms
that bring about the split of Teff population into two subpop-
ulations: “consumers” and “producers.” “Consumers” have shut
down their IL-2 secretion, but have plenty of IL-2Rα that allows
them to “steal” IL-2 from “producers.” The “producers” are stuck
in IL-2 secretion state since they have few IL-2Rα and so little
chances of starting signaling and changing their state as their IL-2
is being stolen by the “consumers.” This consideration implies that
a continuum of IL-2Rα levels within the Teff cell population may
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yields to a digital split between IL-2 consumers and producers,
with functional consequence in terms of differentiation (effector
vs. memory phenotypes). Note that the heterogeneity between
producers and consumers is not exclusively due to negative feed-
back in IL-2 secretion, as production is heterogeneous from the
outset (Hollander et al., 1998; Podtschaske et al., 2007). This has
been particularly well studied in the context of other cytokines
(Mariani et al., 2010), but results to be published will confirm this
endogenous variability in IL-2 production. Ultimately, competi-
tion for cytokines and heterogeneity in T cell signaling are critical
contributors for T cell diversification during differentiation. For
example, Catron et al. (2006) found that antigen-specific CD4+
cells arriving late into the draining lymph node divide less and
their progeny is more likely to become memory cells than that of
resident cells.
MODELING THE IL-2 TUG-OF-WAR BETWEEN Treg AND Teff
CELLS: A SYSTEMS IMMUNOLOGY CHALLENGE
A conspicuous feature of IL-2 and other T cell cytokines is their
action as both autocrine and paracrine messengers. Thus a key
question in understanding the physiological effects of cytokines
is: which cells actually receive the cytokine signal? Does the secret-
ing cell consume most of it in an autocrine manner, or is it quickly
distributed to neighboring cells – and if so, how far does the signal
travel in space? Moreover, cytokine signaling is likely to be highly
dynamic in time and space since cytokines regulate the expression
of genes involved in the signaling – most prominently cytokine
genes themselves as well as cytokine receptor genes.
To understand how the rates of cytokine production, diffu-
sion, and cellular consumption as well as the feedback regulation
of cytokine signaling shape the biological action of a cytokine,
mathematical models provide an appropriate tool. Such models
incorporate in a systematic way the kind of arguments made
in the previous section, in order to simulate the dynamics of
cytokine signaling for populations of secreting consuming and
signaling cells. Two recent studies have employed a combination
of experiments and mathematical modeling to dissect IL-2 sig-
naling between antigen-activated, IL-2 secreting CD4 T cells and
regulatory T cells (Busse et al., 2010; Feinerman et al., 2010). These
studies provide mechanistic insight into how a single cytokine can
serve as a messenger to two opposing T cell subsets.
Our two theoretical models describe the binding of IL-2 to IL-2
receptors, downstream signal transduction via the Stat5 pathway
and activation of IL-2Rα gene expression (Figure 1A). Feinerman
et al. (2010) provide a detailed description of signal transduc-
tion and its cell-to-cell heterogeneity and also include feedback
repression of the IL-2 gene. Busse et al. (2010) study the spatial
aspect of signaling in dense cell assemblies that is governed by
the interplay between IL-2 diffusion and competitive uptake. Var-
ious experimental measurements were used by our two groups to
parameterize these models and make testable predictions.
Both quantitative models consistently show that there exist
three very different biological outcomes of IL-2 secretion by
antigen-stimulated responder T cells, depending on two parame-
ters: (1) the rate of IL-2 secretion and (2) the presence (or absence)
of proximal Treg cells. In the absence of Treg cells, even weak anti-
genic stimulation of responder T cells and, correspondingly, low
IL-2 secretion rates are sufficient to upregulate expression of IL-
2Rα and trigger the IL-2/Stat5 pathway in the responder T cells.
By contrast, in the presence of Treg cells that constitutively express
IL-2Rα, the Treg cells will completely deprive responder T cells of
their own IL-2 and prevent Stat5 activation. Thus, with a stim-
ulation at low concentration of antigens, the outcome of IL-2
signaling is dichotomic: either the responder T cells receive the
signal (no Treg cells present) or it is completely consumed by the
Treg cells (Figure 1B). IL-2 deprivation by Treg cells will therefore
quench spurious activation events and sharpen the antigen activa-
tion threshold (Figure 1C). However, strongly antigen-stimulated
responder T cells will produce sufficient IL-2 so that both the
responder T cells and nearby Tregs will share the signal. As IL-2
primes Treg cells for later IL-10 expression in vivo (Brandenburg
et al., 2008), this sharing of IL-2 can both support an immune
response and initiate a delayed negative feedback loop (Scheffold
et al., 2005; Yamaguchi et al., 2011). Taken together, these find-
ings provide a mechanistic underpinning for IL-2 competition as
a suppressive mode of Treg cells that depends on the strength of
the antigen stimulus (de la Rosa et al., 2004; Barthlott et al., 2005;
Pandiyan et al., 2007; McNally et al., 2011).
The positive feedback regulation of IL-2Rα chain expression by
IL-2/Stat5 signaling plays a critical role in this regulatory network.
In responder T cells, full IL-2Rα expression and formation of high-
affinity IL-2 receptors requires, in addition to the antigen stimulus,
phosphorylation of Stat5. Hence Treg cells, which constitutively
express IL-2Rα, will deprive of IL-2 weakly stimulated respon-
der T cells (here, cells that fail to upregulate IL-2Rα sufficiently)
and keep them from expressing high-affinity IL-2 receptors, thus
inflicting a“double hit”(Feinerman et al., 2010). However, if IL-2 is
abundant (strongly stimulated) responder T cells upregulate their
own IL-2Rα expression due to positive feedback. These activated
cells do no longer suffer from IL-2 deprivation by Tregs because
they have themselves become efficient sensors and consumers of
the cytokine. Under conditions where IL-2Rα is limiting for the
formation of high-affinity IL-2 receptors, the IL-2–IL-2Rα posi-
tive feedback can function as a digital switch that converts graded
changes in the antigen stimulus into an all-or-nothing decision
for cell proliferation at the single-cell level (Busse et al., 2010).
Quantitation of the IL-2R subunit expression and resulting Stat5
phosphorylation in responder T cells shows that both IL-2Rα and
IL-2Rβ levels control the responsiveness of a cell to IL-2. More-
over, cell-to-cell variability in the expression of both receptor
subunits results in a broad distribution of IL-2 sensitivities in a
cell population (Feinerman et al., 2010).
Interestingly, a recent systems-biology study of an unrelated
cytokine pathway, Epo signaling in erythroid progenitors, has
shown a key role for signal processing of cytokine consumption
by rapid receptor turnover (Becker et al., 2010). However, what
makes the IL-2–IL-2R system ideally suited for cytokine com-
petition is the positive feedback regulation of receptor (IL-2Rα)
expression in both responder T cells and Treg cells. Through this
self-amplification of IL-2 signaling and consumption, rather sub-
tle initial differences in strength and timing of antigen stimulation
can lead to clear-cut biological outcomes (Feinerman et al., 2010).
An important question that has already been introduced in the
discussion of the transwell assay is how far a cytokine signal can
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FIGURE 1 | Sketch of the feedback involved in the regulation of IL-2
response. Antigenic engagement of Teff cells leads to their activation, with
IL-2Rα upregulation and IL-2 production (A). Studies by our groups (Busse
et al., 2010; Feinerman et al., 2010) quantified the strength of feedback
regulations on IL-2 signaling and secretion. In particular, the role of Treg cells
(whose constitutive expression of IL-2Rα allows early IL-2 depletion) in
regulating STAT5 phosphorylation in Teff cells was modeled in silico. Three
main predictions from our models were validated experimentally: (1) Treg can
impact a double suppressive hits on Teff cells by blocking IL-2Rα upregulation
and IL-2 accumulation hence abrogating STAT5 phosphorylation (B); (2) This
suppression is highly dynamic and variable: in particular, Treg cells can rely on
the competition for IL-2 to block the proliferation of weakly activated Teff
cells, while allowing strongly activated Teff cells to mount an immune
response (C); note how the presence of Treg cells reduce the overall
proliferation of Teff cells but, as well, sharpen the dose responsive curve for
proliferation vs. antigen strength; (3) Complex spatio-temporal coupling
allow Treg cells to modulate and regulate the extent of suppression in
crowded environments (e.g., in vivo).
Frontiers in Immunology | T Cell Biology September 2012 | Volume 3 | Article 268 | 6
Höfer et al. Quantitative modeling of IL-2 tug-of-war
travel in space – Section “Three Experimental Evidences Against a
Role for IL-2 Depletion as a Mechanism for Treg Suppression can
be Mitigated.” Clearly, diffusion over mm-range distances, with
diffusion times of several hours (as in the transwell setup), is
prohibitive for efficient communication. However, a biologically
more relevant question is whether cytokine gradients occur on
a smaller scale that could compartmentalize cell-to-cell signaling
in lymphoid organs. For in vitro experiments, Feinerman et al.
(2010) estimated that diffusion through the supernatant would
not allow steep concentration gradients to develop (and moreover,
convection, which is much faster than diffusion over larger dis-
tances, is also likely to occur in typical in vitro setups). By contrast,
the explicit modeling of diffusion in rather dense cell assemblies
(where extracellular space and total cell volume are of comparable
magnitude) show that competitive IL-2 uptake under conditions
of limited supply can cause strong concentration gradients (Busse
et al., 2010). This is particularly evident for Treg cells, which due to
their high constitutive IL2-Rα expression function as potent sinks
of the cytokine. As a consequence, Treg cells can absorb the IL-2
secreted by localized, weakly stimulated responder T cells and thus
prevent the paracrine spread of this signal to other responder T
cells in the neighborhood. On the other hand, when IL-2 secre-
tion is strong (owing to a high fraction of secreting responder
T cells and/or high secretion rates), Treg cells will become satu-
rated and the IL-2 signal could pervade an entire lymph node [as
shown previously for IL-4 (Perona-Wright et al., 2010)]. In sum-
mary, the modeling suggests that Treg cells also control the spatial
propagation of IL-2 signals in lymphoid organs.
By iterating between modeling and experiments, the studies
by Busse et al. (2010) and Feinerman et al. (2010) have revealed
an unexpected plasticity of the IL-2 cytokine network, where
quantitative parameters (secretion rate, diffusion, and competitive
uptake) shape the biological outcome. Further theoretical studies
have modeled T cell population dynamics and IL-2 signaling (Bur-
roughs et al., 2006), making experimentally testable predictions.
As several other cytokines of the adaptive immunity share prin-
ciple features of the IL-2 system, especially competitive uptake by
different cell populations and feedback regulation of signaling, we
expect that similar “behavioral” plasticity will be found also in
other cytokine networks.
PERTURBING THE IL-2 TUG-OF-WAR TO MAXIMIZE
IMMUNOTHERAPEUTIC IMPACT
At the same time as the issue of cytokine competition was
being revisited, pre-clinical and clinical studies have put for-
ward the possibility of applying IL-2 treatments to manipulate
the Treg compartment and impact on clinical outcomes (Mur-
phy et al., 2012). Specifically, using antibody to cross-link IL-2
and to increase its lifetime in vivo (bare IL-2, because of its
low molecular weight, gets filtered out of the system, mostly in
the kidneys), researchers discovered that the Treg compartment
could be expanded. For example, Boyman and colleagues achieved
proliferation of CD4+FoxP3+ lymphocytes in mice, increasing
the frequency of Treg cells by 10-fold, 3 days post-injection of
the cytokine/antibody complex (Webster et al., 2009). The func-
tional significance of this observation was immediately tested on
a model of experimental autoimmune encephalomyelitis (EAE)
whose induction could be abrogated after such robust Treg cell
expansion.
Similar observations (whereby the Treg compartment is
expanded with high levels of IL-2Rα and enhanced suppressive
capacities) have been reported in other models. The Bluestone
group applied a low-dose regiment of IL-2 to NOD mice, and
obtained a strong delay or complete abrogation of diabetes (Tang
et al., 2008): concomitantly, they reported that Treg cells harvested
from the pancreatic islet were more abundant (27% instead of
7% among CD4+ T cells) and expressed higher levels of IL-2Rα
(20-fold higher). Similar results were obtained in a clinical setting,
whereby low-dose regimen of IL-2 was demonstrated to be suf-
ficient to delay the onset of Graft-vs.-Host-disease in allogeneic
bone marrow transplant settings (Koreth et al., 2011). Again, these
results should be analyzed quantitatively to test whether the sub-
tle balance between immune response (autoimmune attack of
the pancreatic islet or allogeneic activation of graft T cells) and
immune tolerance (suppression of activation and proliferation)
could result from the boosted ability of Treg cells to compete
for cytokines. A model for such immunotherapeutic intervention
has already been proposed and makes further experimental test-
ing critical. IL-2 regimen clearly upregulates IL-2Rα levels (with
enhanced ability to bind and deplete IL-2), but it could also trig-
ger other suppression mechanisms (e.g., secretion of IL-10 or
upregulation of CTLA4).
Further quantitative modeling of this cytokine competition
within clinical settings will thus be necessary to test and opti-
mize cytokine competition,mostly to block autoimmune disorders
using natural suppressive capabilities, but also to boost cytotoxic
impact in cancer immunotherapies (2012). Although, this may
prove difficult as direct and repeated probing of the tissue of inter-
est (skin in GvHD, pancreatic islets in diabetes), we conjecture that
mathematical models will become more and more critical to inter-
pret functional changes as measured among accessible peripheral
blood mononuclear cell (e.g., IL-2Rα upregulation in an expanded
Treg compartment) and extrapolate them to the tissue of rele-
vance. Note that accurate measurements of in vivo concentrations
of cytokines would go a long way toward resolving issues about
cytokine communications in the immune system: this remains a
challenging task given the low levels of free cytokine within tissues,
but technical developments (ELISA miniaturization and the use
of physiological reporters for cytokines) will solve this problem
in the coming years. Ultimately, mouse pre-clinical models will
be particularly useful to fine-tune the blood-to-tissue quantitative
interpolation of immune responses.
CONCLUSION
We presented a review of recent efforts in Systems Immunology
that aim at addressing the role of cytokine competition as one
mechanism of immune suppression by Treg cells. Modeling quan-
titatively how cytokine is secreted by effector T cells undergoing
activation, and how much gets scavenged by regulatory T cells
remains challenging because of the dynamic complexity of the
system. However, computational models have already highlighted
the spatio-temporal intricacies of IL-2 competition: depending on
the speed of IL-2Rα upregulation among Teff cells, there exists a
time window when Treg cells deplete the extracellular medium of
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the secreted IL-2 and “snuff” this critical cytokine for differentia-
tion. Spatially, the tight-packed space of lymphoid organs as well
as the high density of polyclonal Treg cells with high tonic level of
IL-2Rα expression can limit the spatial extent at which Teff cells
can communicate through IL-2 sharing. This in turns, can act as a
differential regulatory mechanisms to discriminate between acti-
vation of Teff cells with low or high concentrations of antigens.
Future work will need to extend the modeling framework intro-
duced for IL-2 to other cytokines (e.g., IL-4, IL-10, TGFβ) as well
as other costimulatory signals (e.g., B7/CTLA4). Further model-
ing effort will need to deal with cell proliferation and homeostasis,
as proposed in a recent study (Burroughs et al., 2011; Almeida
et al., 2012). These quantitative approaches will contribute greatly
to assess the relevance of these varied mechanisms of Treg cell
suppression in vitro and in vivo. Beyond fundamental immunol-
ogy, such quantitative insight may open new avenues of cytokine
perturbation, to maximize immunotherapeutic impact in clinical
settings.
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